Clinical Trials Browser

Phase 4 × Glioma × Clear all

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

NCT06625047 2026-04-29

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Phase 4 Completed

30 enrolled

CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

NCT03340506 2026-04-20

Dabrafenib and/or Trametinib Rollover Study

Phase 4 Recruiting

100 enrolled

CNSDermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Lung Neoplasms, Melanoma

NCT07486713 2026-03-20

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

Phase 4 Recruiting

16 enrolled

CNSGastrointestinalOther hematologic neoplasm

Glioma, Neoplasms, Leukemia, Myeloid, Acute, Cholangiocarcinoma

NCT05342883 2025-09-05

GESTALT

Phase 4 Active not recruiting

61 enrolled

CNS

Glioblastoma, Glioma, Neoplasms

NCT03048084 2025-02-04

STING

Phase 4 Recruiting

120 enrolled

CNS

Glioma

NCT04650204 2023-06-22

Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy

Phase 4 Terminated

4 enrolled 9 charts

CNS

Drug Resistant Epilepsy, Epilepsy, Glioma

Clinical Trials

Pediatric Long-Term Follow-up and Rollover Study

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Dabrafenib and/or Trametinib Rollover Study

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

GESTALT

STING

Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy